Antiplatelet and anticoagulant therapy to prevent bypass graft thrombosis in patients with lower extremity arterial occlusive disease

Keyphrases

• Bypass Graft 100%
• Antiplatelet Therapy 100%
• Graft Failure 100%
• Graft Thrombosis 100%
• Anticoagulant Therapy 100%
• Lower Extremity Arterial Disease 100%
• Polytetrafluoroethylene 33%
• Selection Strategy 33%
• Knee 33%
• Clinical Significance 33%
• Pharmacological Agents 33%
• Failure Rate 33%
• Poor Outcome 33%
• Operative Technique 33%
• Critical Limb Ischemia 33%
• Patient Selection 33%
• Graft Patency 33%
• Vein Graft 33%
• Peripheral Arterial Disease 33%
• Prosthetic Grafts 33%
• Femoropopliteal 33%
• European Consensus 33%
• Evidence-based Recommendations 33%
• Economic Importance 33%
• Consensus Document 33%
• Grafting from 33%
• Early Failure 33%
• Prosthetic Material 33%
• Peripheral Vascular Surgery 33%
• Vessel Stenosis 33%
• Surgical Reintervention 33%
• Primary Graft Dysfunction 33%

Medicine and Dentistry

• Bypass Surgery 100%
• Arteriosclerosis Obliterans 100%
• Antiplatelet 100%
• Graft Failure 100%
• Thrombosis 100%
• Anticoagulant Therapy 100%
• Prosthetics 50%
• Surgical Technique 25%
• Knee 25%
• Atherosclerosis 25%
• Politef 25%
• Graft Patency 25%
• Vascular Surgery 25%
• Patient Selection 25%
• Stenosis 25%
• Critical Limb Ischemia 25%
• Antithrombotic 25%
• Femoropopliteal Bypass 25%
• Grafting Procedure 25%